Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Thalia Therapeutics said a Chinese patent has been granted for miRisten, its lead clinical-stage programme for acute myeloid leukaemia. The company said the patent extends intellectual property protection for the programme in China.
Alterity Therapeutics announces granting of new US composition of matter patent for ATH434